top of page

FDA Announces Voluntary Recall Of Ranitidine Capsules

Writer's picture: Zantac Lawsuit Justice CenterZantac Lawsuit Justice Center

The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc., used to decrease the amount of acid created by the stomach. This recall is due to a nitrosamine impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled medicine. NDMA is classified as a probable human carcinogen (a substance that could cause cancer).


“The FDA is committed to ensuring that the medicines Americans take are safe and effective. We began testing ranitidine products immediately after we learned of the potential impurity. When we identify lapses in the quality of drugs that pose potential risks for patients, the FDA makes all efforts to understand the issue and provide our best recommendation to the public as quickly and accurately as possible,” said Acting FDA Commissioner Ned Sharpless, M.D. “We will continue to investigate and work to ensure these types of impurities do not exceed acceptable limits, so that patients can continue taking the medicines they need without concern.” 


The FDA Announces Voluntary Recall Of Ranitidine

Ranitidine is an over-the-counter (OTC) and prescription drug. Ranitidine is a histamine-2 blocker, which decreases the amount of acid created by the stomach. OTC ranitidine is approved to prevent and relieve heartburn associated with acid ingestion and sour stomach. Prescription ranitidine is approved for multiple indications, including treatment and prevention of ulcers of the stomach and intestines and treatment of gastroesophageal reflux disease. The agency today provided the following information for patients and health care professionals on the recall of ranitidine capsules produced by Sandoz:

  • If a patient is taking one of the recalled medicines, they should follow the recall instructions provided by the company. This information is available on the FDA’s website.

  • While the FDA investigates the root cause and risk, consumers and patients can continue to take ranitidine that has not been recalled. It is important to remember that not all ranitidine marketed in the U.S. is being recalled.

  • Patients taking prescription ranitidine who wish to discontinue use should talk to their health care professional about other treatment options. Multiple drugs are approved for the same or similar uses as ranitidine.

  • Consumers taking OTC ranitidine could consider using other OTC products for their condition.

“We are continuing our investigation along with our international counterparts, and we will keep the American public informed of any additional recalls as well as the potential risks from taking ranitidine products,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research.


The agency is testing ranitidine products from multiple manufacturers and assessing the possible effect on patients who have been taking ranitidine, as well as what manufacturers can do to reduce or eliminate nitrosamine in drugs.


As part of the FDA’s investigation, the agency recently posted a testing protocol, which can be used by regulators and industry to detect nitrosamine impurities in ranitidine. The FDA is asking companies to begin their own laboratory testing to examine levels of NDMA in ranitidine and to send samples of ranitidine to the FDA to be tested by agency scientists.

The FDA and manufacturers of ranitidine will take appropriate measures based on the results of this ongoing investigation and the agency will provide additional information when it becomes available. The FDA encourages patients and health care professionals to report any adverse reaction to the agency’s MedWatch program.


The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

12 views0 comments

Recent Posts

See All

Comments


Zantac Lawsuit Attorneys Lawyers

Diagnosed With Cancer After Taking Zantac or Another Ranitidine Product?

You May Be Entitled To Compensation

Zantac Lawsuit | Settlement & Class Action
  • White LinkedIn Icon
  • Facebook | Zantac Lawsuit

© 2023 ZantacLawsuit.com. All Rights Reserved. (Privacy Policy)

The information provided by ZantacLawsuit.com is not a substitute for professional medical advice, diagnosis or treatment. The views and opinions expressed on the site do not necessarily represent those of ZantacLawsuit.com. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your client's copyright, we may be contacted concerning copyright matters at: info@zantaclawsuit.com. THIS IS A PAID LEGAL ADVERTISEMENT. This is not a law firm or referral service and does not provide legal advice. This is a free connection service only and there is no charge to be connected with an attorney. Claim reviews will be performed by a third party attorney and the attorney who receives your information may not offer a free claim evaluation. This is not a substitute for medical advice from your doctor, so never start or stop taking medication without consulting a doctor first. We do not recommend or endorse any attorneys that pay to participate in this advertisement. An attorney-client relationship is not formed when you submit the form and you are under no obligation to retain a lawyer who contacts you through this service. Services are not available in all states. This website is not affiliated in any way with any pharmaceutical company, drug producer, or attorney, and makes no claim to any registered trademarks or brands of any company. We help you find information to fight for your rights!

bottom of page